Vaccinomics: a future avenue for vaccine development against emerging pathogens

Area of Science:

• Vaccinology
• Immunology
• Genomics
• Proteomics
• Metabolomics

Background:

• Vaccines are crucial for controlling infectious diseases, but developing more effective ones against emerging pathogens remains a challenge.
• Omics technologies have improved vaccinology by characterizing molecular interactions and identifying protective antigens.
• Challenges include host immunity, pathogen factors, environmental influences, and vaccine safety and efficacy.

Purpose of the Study:

• To review current knowledge on vaccinomics.
• To propose quantum vaccinomics as an advanced approach for vaccine development.
• To highlight the potential of quantum vaccinomics in addressing challenges in vaccine efficacy and safety.

Main Methods:

• Review of existing literature on vaccinomics and omics technologies.
• Proposal of quantum vaccinomics principles and applications.
• Discussion of antigen identification and epitope combination strategies.

Main Results:

• Vaccinomics provides a platform to address challenges in vaccine development.
• Quantum vaccinomics can enhance vaccine efficacy and safety.
• This approach facilitates the identification and combination of protective epitopes.

Conclusions:

• Vaccines are essential for controlling emerging infectious diseases.
• Vaccinomics and quantum vaccinomics offer promising strategies to improve vaccine development, efficacy, and safety.
• Quantum vaccinomics can aid in targeting pathogen infection and transmission.